Jutta K. Neuenburg

Jutta K. Neuenburg, MD PhD, currently serves as Medical Director at Pharmacyclics, an AbbVie Company, since August 2013. Previously, Jutta held the position of Medical Director at Dynavax Technologies, focusing on clinical research in immunology and Toll-like Receptor biology, as well as experience at Genentech and BioMarin in autoimmune diseases and drug development. An academic background includes roles as Assistant Professor of Medicine at UCSF Medical Center and Postdoctoral Fellow at The Gladstone Institutes, specializing in immune tolerance and neuroimmunology. Jutta completed a PhD in Neuroimmunology and an MD from Goethe University Frankfurt, along with advanced training and certification in clinical research and business excellence from prestigious institutions.